Corcept Therapeutics: Stress in the Fight Against Stress Hormones
![](https://tradertimes.com/files/2025/01/Shu-Corcept-Therapeutics-720250124-2554047409-1140x440.png)
Reading Time: 3 minutes
Hope Bearer Against Stress Hormones : With Korlym and Relacorilant, Corcept aims to regulate the stress hormone cortisol – an approach with potential for numerous indications. Allegations and Competitive Pressure : Allegations of bribery, off-label marketing, and generic alternatives burden the company despite its innovative approaches. Corcept Therapeutics has secured a leading position in the rare disease sector, particularly in Cushing's Syndrome , through its specialization in modulating the stress hormone Cortisol . While the company...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.